Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$3.25 - $4.72 $208,529 - $302,849
-64,163 Reduced 68.65%
29,302 $96,000
Q1 2024

Apr 25, 2024

BUY
$2.77 - $4.22 $199,126 - $303,363
71,887 Added 333.15%
93,465 $305,000
Q4 2023

Feb 02, 2024

SELL
$1.47 - $6.06 $73,589 - $303,369
-50,061 Reduced 69.88%
21,578 $75,000
Q3 2023

Nov 01, 2023

BUY
$6.11 - $8.16 $437,714 - $584,574
71,639 New
71,639 $478,000
Q1 2023

Apr 27, 2023

BUY
$5.77 - $9.93 $388,465 - $668,537
67,325 New
67,325 $668,000
Q2 2022

Aug 03, 2022

SELL
$2.43 - $4.85 $258,775 - $516,486
-106,492 Reduced 77.31%
31,249 $124,000
Q1 2022

May 02, 2022

BUY
$3.25 - $5.17 $143,006 - $227,490
44,002 Added 46.94%
137,741 $612,000
Q4 2021

Feb 23, 2022

BUY
$3.5 - $9.63 $255,251 - $702,306
72,929 Added 350.45%
93,739 $374,000
Q3 2021

Oct 28, 2021

SELL
$7.94 - $11.31 $913 - $1,300
-115 Reduced 0.55%
20,810 $235,000
Q2 2021

Aug 12, 2021

BUY
$10.44 - $14.85 $76,827 - $109,281
7,359 Added 54.25%
20,925 $237,000
Q1 2021

Apr 26, 2021

SELL
$6.53 - $14.42 $20,771 - $45,870
-3,181 Reduced 18.99%
13,566 $161,000
Q4 2020

Feb 02, 2021

BUY
$6.31 - $8.13 $99,716 - $128,478
15,803 Added 1674.05%
16,747 $114,000
Q3 2020

Oct 14, 2020

SELL
$4.0 - $7.53 $836 - $1,573
-209 Reduced 18.13%
944 $6,000
Q2 2020

Jul 13, 2020

SELL
$1.97 - $5.05 $6,631 - $16,998
-3,366 Reduced 74.49%
1,153 $4,000
Q1 2020

Apr 29, 2020

BUY
$1.62 - $6.4 $7,320 - $28,921
4,519 New
4,519 $11,000
Q4 2019

Feb 05, 2020

SELL
$4.73 - $7.98 $2,748 - $4,636
-581 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$4.41 - $6.12 $2,562 - $3,555
581 New
581 $3,000
Q1 2019

Apr 18, 2019

SELL
$7.14 - $9.85 $1,120 - $1,546
-157 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$7.26 - $13.29 $425,348 - $778,634
-58,588 Reduced 99.73%
157 $1,000
Q3 2018

Oct 23, 2018

BUY
$6.8 - $14.35 $379,215 - $800,256
55,767 Added 1872.63%
58,745 $810,000
Q2 2018

Jul 30, 2018

BUY
$6.95 - $9.18 $19,307 - $25,502
2,778 Added 1389.0%
2,978 $23,000
Q1 2018

Apr 26, 2018

BUY
$6.55 - $8.9 $1,310 - $1,780
200 New
200 $1,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $283M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.